Not available
Quote | Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX)
Last: | $17.59 |
---|---|
Change Percent: | -1.38% |
Open: | $17.61 |
Close: | $17.59 |
High: | $17.86 |
Low: | $17.38 |
Volume: | 645,215 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX)
2024-07-24 14:22:21 ET More on Catalyst Pharmaceuticals Catalyst Pharmaceuticals: New Products In Proving Phase Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript HHS panel to vote in Nov. on DMD screening for newborns Catalyst Pharmaceuti...
CORAL GABLES, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-...
Message Board Posts | Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CPRX News Article - Catalyst Pharmaceuticals Announces Release of Inaugural ESG Report | whytestocks | investorshangout | 05/01/2023 4:35:51 PM |
whytestocks: $CPRX News Article - Catalyst Pharmaceuticals Named BioFlorida 2022 Company of the Year | whytestocks | investorshangout | 11/07/2022 3:40:51 PM |
whytestocks: $CPRX News Article - These 3 Stocks Are Winning the Bear Market -- Here's How | whytestocks | investorshangout | 10/21/2022 3:30:49 PM |
AviseAnalytics: CATALYST PHARMACEUTICALS: NEXT BIG THING ON S&P SMALLCAP 600 $CPRX Excited to sh | AviseAnalytics | investorshangout | 09/14/2022 12:33:24 PM |
znewcar1: CPRX 23% v4,1M c13.13 f102,8M H13.24ML7.36 | znewcar1 | investorshangout | 08/10/2022 9:49:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Catalyst Pharmaceuticals Inc. Company Name:
CPRX Stock Symbol:
NASDAQ Market:
Catalyst Pharmaceuticals Inc. Website:
CORAL GABLES, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-...
CORAL GABLES, Fla., July 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-...
2024-06-20 17:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...